Stefanie K. Gräfe

992 total citations
6 papers, 102 citations indexed

About

Stefanie K. Gräfe is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Stefanie K. Gräfe has authored 6 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Epidemiology and 1 paper in Surgery. Recurrent topics in Stefanie K. Gräfe's work include Microscopic Colitis (2 papers), Antifungal resistance and susceptibility (2 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Stefanie K. Gräfe is often cited by papers focused on Microscopic Colitis (2 papers), Antifungal resistance and susceptibility (2 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Stefanie K. Gräfe collaborates with scholars based in Germany, Switzerland and Sweden. Stefanie K. Gräfe's co-authors include Danila Seidel, Jon Salmanton‐García, Oliver A. Cornely, Ulrik Lindforss, Birgitta Agerberth, Maarten Coorens, Peter Bergman, Anna Rao, Jenny Mjösberg and Reham Khedr and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Microbiology and Infection and Journal of Hospital Infection.

In The Last Decade

Stefanie K. Gräfe

5 papers receiving 102 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie K. Gräfe Germany 4 58 48 24 19 13 6 102
Daisuke Jubishi Japan 8 68 1.2× 21 0.4× 49 2.0× 14 0.7× 9 0.7× 23 136
Jobst Röhmel Germany 8 31 0.5× 28 0.6× 23 1.0× 12 0.6× 13 1.0× 14 210
Beata Zamlynny United States 2 50 0.9× 39 0.8× 13 0.5× 62 3.3× 11 0.8× 3 102
Alexandra N. Donlan United States 7 137 2.4× 32 0.7× 33 1.4× 39 2.1× 9 0.7× 9 192
Fatma Çölkesen Türkiye 5 67 1.2× 25 0.5× 16 0.7× 22 1.2× 4 0.3× 14 121
Alina N. Egorova Russia 5 32 0.6× 39 0.8× 89 3.7× 11 0.6× 8 0.6× 8 157
Lauren Walker United States 6 50 0.9× 18 0.4× 45 1.9× 39 2.1× 5 0.4× 7 124
Claudia A. Rivera France 6 64 1.1× 88 1.8× 21 0.9× 83 4.4× 12 0.9× 9 187
Adelina Amorim Portugal 11 42 0.7× 54 1.1× 17 0.7× 6 0.3× 46 3.5× 39 236
Wanzhou Xu China 7 77 1.3× 50 1.0× 20 0.8× 5 0.3× 5 0.4× 12 143

Countries citing papers authored by Stefanie K. Gräfe

Since Specialization
Citations

This map shows the geographic impact of Stefanie K. Gräfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie K. Gräfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie K. Gräfe more than expected).

Fields of papers citing papers by Stefanie K. Gräfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie K. Gräfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie K. Gräfe. The network helps show where Stefanie K. Gräfe may publish in the future.

Co-authorship network of co-authors of Stefanie K. Gräfe

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie K. Gräfe. A scholar is included among the top collaborators of Stefanie K. Gräfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie K. Gräfe. Stefanie K. Gräfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
2.
Conrad, J., Stefanie K. Gräfe, Asad Ullah, et al.. (2024). Comparative effectiveness of vancomycin and metronidazole on event-free survival after initial infection in patients with Clostridioides difficile—a German multicentre cohort study. Clinical Microbiology and Infection. 30(11). 1433–1438. 2 indexed citations
3.
Tsakmaklis, Anastasia, et al.. (2021). Biomarkers of Human Gut Microbiota Diversity and Dysbiosis. Biomarkers in Medicine. 15(2). 139–150. 16 indexed citations
4.
Stemler, Jannik, Kamal Hamed, Jon Salmanton‐García, et al.. (2020). Mucormycosis in the Middle East and North Africa: Analysis of the FungiScope® registry and cases from the literature. Mycoses. 63(10). 1060–1068. 38 indexed citations
5.
Coorens, Maarten, Anna Rao, Stefanie K. Gräfe, et al.. (2019). Innate lymphoid cell type 3–derived interleukin-22 boosts lipocalin-2 production in intestinal epithelial cells via synergy between STAT3 and NF-κB. Journal of Biological Chemistry. 294(15). 6027–6041. 31 indexed citations
6.
Koehler, Philipp, Jon Salmanton‐García, Stefanie K. Gräfe, et al.. (2019). Baseline predictors influencing the prognosis of invasive aspergillosis in adults. Mycoses. 62(8). 651–658. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026